The recent disruptions in global supply have highlighted the necessity of securing vital medications like Ivermectin. Trusting on overseas manufacturers exposes nations to potential vulnerabilities, including transportation delays, expense fluctuations, and even political risks. Shifting towards domestic procurement of Ivermectin offers a multitude